Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Allscripts Healthcare Solutions

Share:
Related MDRX
Allscripts Has 20% Upside: Deutsche Bank Upgrades Stock To Buy
The Market In 5 Minutes

In a report published Friday, Jefferies & Company reiterated its Hold rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), but lowered its price target from $13.00 to $10.00.

Jefferies noted, “This morning's call revealed few additional details of the bidding process and outcome. Deal will not bail investors out of this name in 2012. MDRX's new management seems intent on executing the existing strategy: offering an integrated solution and building out its service portfolio. After today's trading the stock is cheap, but we would like to see evidence of traction to ensure EBITDA doesn't shrink further.”

Allscripts Healthcare Solutions closed on Thursday at $9.14.

Latest Ratings for MDRX

DateFirmActionFromTo
Mar 2017Wells FargoUpgradesMarket PerformOutperform
Feb 2017DoughertyUpgradesNeutralBuy
Jan 2017Cantor FitzgeraldInitiates Coverage OnNeutral

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!